In December 2003, physicians treating patients with bipolar mania gained a new treatment option with the FDA-approval of risperidone (Risperdal®) used alone or in combination with lithium or valproate. The FDA approved risperidone for the short-term treatment of acute manic or mixed episodes associated with bipolar disorder.

Risperidone is now the most commonly prescribed antipsychotic medication in the United States.

However, risperidone has received a "not approved" letter from the FDA for use in autism.

Please visit the official site of the FDA for further information.

 

Why is this medication prescribed?

Other uses for this medicine

Dosage and using this medicine

What special precautions should I follow?

What should I do if I forget a dose?

What side effects can this medication cause?

What storage conditions are needed for this medicine?

In case of an emergency/overdose